Literature DB >> 15906111

Raynaud's phenomenon in a healthy Turkish population.

Kevser Onbaşi1, Idris Sahin, Okan Onbaşi, Yusuf Ustün, Doğan Koca.   

Abstract

Raynaud's phenomenon (RP) is a vasospastic disease and is characterized by ischemia of the digits, nose, and ears. The vasospasm can be triggered by cold weather, cold water, or emotional stress and is followed by triphasic color changes. First white color (ischemia), then blue color (congestion and cyanosis), and finally red color change (reactive hyperemia) can be observed. The prevalence is reported to be between 0.5 and 20% in different studies and is dependent on genetic, occupational, and environmental factors. The purpose of our study was to determine the prevalence of RP in an eastern part of Turkey among healthy subjects. A total of 768 people were included in the study. This cross-sectional study was conducted between April 2003 and October 2003 at the University Hospital and at the State Hospital in Van, Turkey. The participants were interviewed and examined to diagnose RP and a questionnaire and color charts were used. Of these 768 patients, 25 women and 20 men were diagnosed to have RP. A female predominance (25/20) was observed. Their mean age was 24.78 +/- 5.71 years. The prevalence of RP was 5.9% in our study population.

Entities:  

Mesh:

Year:  2005        PMID: 15906111     DOI: 10.1007/s10067-004-1045-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

Review 1.  Raynaud's phenomenon.

Authors:  J A Block; W Sequeira
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

Review 2.  Clinical practice. Raynaud's Phenomenon.

Authors:  Fredrick M Wigley
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

3.  "Primary Raynaud's" is not a disease or even a disorder; it's a trait.

Authors:  N M Hadler
Journal:  J Rheumatol       Date:  1998-12       Impact factor: 4.666

4.  Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.

Authors:  I Valter; H R Maricq
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

5.  Primary Raynaud's is a disease or a disorder: it is not merely a trait.

Authors:  J J Belch; F Khan
Journal:  J Rheumatol       Date:  1998-12       Impact factor: 4.666

6.  Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

Authors:  H R Maricq; P H Carpentier; M C Weinrich; J E Keil; Y Palesch; C Biro; M Vionnet-Fuasset; M Jiguet; I Valter
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

7.  Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group.

Authors:  P Brennan; A Silman; C Black; R Bernstein; J Coppock; P Maddison; T Sheeran; C Stevens; F Wollheim
Journal:  Br J Rheumatol       Date:  1993-05

8.  Association between Raynaud's phenomenon and migraine in a random population of hospital employees.

Authors:  S T O'Keeffe; N P Tsapatsaris; W P Beetham
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

9.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

10.  Prevalence of Raynaud's phenomenon in general practice in the east of Spain.

Authors:  J A Román Ivorra; J L Gonzálvez Perales; C Fernández Carballido; J Graña; M J Torres
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

View more
  5 in total

1.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

2.  Frequency of rheumatic diseases in patients with autoimmune thyroid disease.

Authors:  Mehmet Soy; Sibel Guldiken; Ender Arikan; Betul Ugur Altun; Armagan Tugrul
Journal:  Rheumatol Int       Date:  2006-11-11       Impact factor: 2.631

3.  Rheumatologic manifestations in Iranian patients with autoimmune thyroid diseases.

Authors:  Sharabeh Hezarkhani; Sima Sedighi; Mehrdad Aghaei; Maryam Shamekhi; Mahin Nomali
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Prevalence of Raynaud's phenomenon in healthy Turkish medical students and hospital personnel.

Authors:  Necati Cakir; Omer Nuri Pamuk; Salim Dönmez; Ahmet Barutçu; Hidayet Diril; Esin Odabaş; Volkan Kiliçcigil
Journal:  Rheumatol Int       Date:  2008-08-06       Impact factor: 3.580

Review 5.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.